DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,164,830 | +3.3% | 4,695 | -0.1% | 0.05% | +6.2% |
| Q2 2023 | $1,128,000 | -2.8% | 4,700 | +2.1% | 0.05% | -7.7% |
| Q1 2023 | $1,160,644 | -10.4% | 4,605 | -5.7% | 0.05% | -13.3% |
| Q4 2022 | $1,295,780 | +1.6% | 4,882 | -1.2% | 0.06% | -6.2% |
| Q3 2022 | $1,276,000 | +1.9% | 4,940 | 0.0% | 0.06% | +8.5% |
| Q2 2022 | $1,252,000 | -7.9% | 4,940 | +6.6% | 0.06% | +9.3% |
| Q1 2022 | $1,360,000 | -59.7% | 4,635 | -54.8% | 0.05% | -14.3% |
| Q4 2021 | $3,372,000 | +105.2% | 10,248 | +89.9% | 0.06% | +37.0% |
| Q3 2021 | $1,643,000 | +15.6% | 5,397 | +1.9% | 0.05% | +15.0% |
| Q2 2021 | $1,421,000 | +18.3% | 5,297 | -0.7% | 0.04% | +8.1% |
| Q1 2021 | $1,201,000 | +1.2% | 5,337 | -0.1% | 0.04% | -2.6% |
| Q4 2020 | $1,187,000 | +0.8% | 5,345 | -2.4% | 0.04% | -13.6% |
| Q3 2020 | $1,178,000 | +30.6% | 5,474 | +4.6% | 0.04% | +18.9% |
| Q2 2020 | $902,000 | +14.5% | 5,231 | -8.2% | 0.04% | -2.6% |
| Q1 2020 | $788,000 | -1.0% | 5,698 | -1.4% | 0.04% | -11.6% |
| Q3 2019 | $796,000 | -10.6% | 5,776 | -7.3% | 0.04% | -12.2% |
| Q2 2019 | $890,000 | +16.3% | 6,230 | +7.3% | 0.05% | +14.0% |
| Q1 2019 | $765,000 | +6.0% | 5,805 | -17.1% | 0.04% | -6.5% |
| Q4 2018 | $722,000 | -6.2% | 7,005 | -1.1% | 0.05% | +12.2% |
| Q3 2018 | $770,000 | +3.6% | 7,082 | -6.0% | 0.04% | +2.5% |
| Q2 2018 | $743,000 | +15.7% | 7,532 | +14.9% | 0.04% | +5.3% |
| Q1 2018 | $642,000 | +12.2% | 6,557 | +6.3% | 0.04% | +18.8% |
| Q4 2017 | $572,000 | +2.9% | 6,166 | -4.8% | 0.03% | -3.0% |
| Q3 2017 | $556,000 | +2.2% | 6,476 | +0.5% | 0.03% | 0.0% |
| Q2 2017 | $544,000 | -3.7% | 6,446 | -2.5% | 0.03% | -8.3% |
| Q1 2017 | $565,000 | -1.2% | 6,609 | -10.0% | 0.04% | -2.7% |
| Q4 2016 | $572,000 | +9.2% | 7,342 | +9.9% | 0.04% | +8.8% |
| Q3 2016 | $524,000 | -25.4% | 6,682 | -3.9% | 0.03% | -27.7% |
| Q2 2016 | $702,000 | +4.6% | 6,951 | -1.6% | 0.05% | +4.4% |
| Q1 2016 | $671,000 | -26.9% | 7,067 | -28.5% | 0.04% | -28.6% |
| Q4 2015 | $918,000 | -6.2% | 9,884 | -13.9% | 0.06% | -11.3% |
| Q3 2015 | $979,000 | -2.9% | 11,484 | -2.4% | 0.07% | +7.6% |
| Q2 2015 | $1,008,000 | -3.3% | 11,772 | -4.0% | 0.07% | -4.3% |
| Q1 2015 | $1,042,000 | -1.8% | 12,267 | -0.9% | 0.07% | -5.5% |
| Q4 2014 | $1,061,000 | +11.8% | 12,379 | -0.8% | 0.07% | +4.3% |
| Q3 2014 | $949,000 | -4.3% | 12,485 | -0.9% | 0.07% | -4.1% |
| Q2 2014 | $992,000 | +6.8% | 12,600 | +1.7% | 0.07% | +4.3% |
| Q1 2014 | $929,000 | -7.2% | 12,385 | -4.5% | 0.07% | -7.9% |
| Q4 2013 | $1,001,000 | +5.5% | 12,970 | -5.2% | 0.08% | 0.0% |
| Q3 2013 | $949,000 | -5.4% | 13,685 | -13.6% | 0.08% | -10.6% |
| Q2 2013 | $1,003,000 | – | 15,847 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |